ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oregon » Medical Oncology

Top Medical Oncology Prescribers in Oregon

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THEODORE BRAICH M.D.

Medical Oncology

4,543

$684K

1009
913 are 65+

3%
patients receiving schedule two controlled substances

Avg: 14%

2%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 17%

$151
Average prescription price

Avg: $428

HERSCHEL WALLEN M.D.

Medical Oncology

1,424

$639K

144
127 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

13%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 17%

$449
Average prescription price

Avg: $428

JOHN SMITH M.D.

Medical Oncology

1,312

$223K

218
166 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 17%

$170
Average prescription price

Avg: $428

BRUCE DANA M.D.

Medical Oncology

1,224

$922K

189
158 are 65+

20%
patients receiving schedule two controlled substances

Avg: 14%

17%
patients receiving schedule three controlled substances

Avg: 6%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 17%

$753
Average prescription price

Avg: $428

WILLIAM MARTIN MD

Medical Oncology

1,093

$676K

197
159 are 65+

10%
patients receiving schedule two controlled substances

Avg: 14%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 17%

$618
Average prescription price

Avg: $428

KATHLEEN FIELDER M.D.

Medical Oncology

996

$250K

132
118 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 17%

$251
Average prescription price

Avg: $428

DOUGLAS LACKOWSKI M.D.

Medical Oncology

992

$859K

227
208 are 65+

23%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 17%

$866
Average prescription price

Avg: $428

JENNIFER LYCETTE MD

Medical Oncology

977

$584K

203
174 are 65+

27%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 17%

$598
Average prescription price

Avg: $428

STEPHEN KORNFELD MD

Medical Oncology

857

$643K

164
130 are 65+

18%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 17%

$750
Average prescription price

Avg: $428

EDWARD SOO M.D.

Medical Oncology

848

$513K

164
131 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 17%

$604
Average prescription price

Avg: $428

REGAN LOOK M.D.

Medical Oncology

832

$196K

119
91 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 17%

$236
Average prescription price

Avg: $428

ALISON CONLIN MD

Medical Oncology

794

$128K

131
109 are 65+

10%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 17%

$161
Average prescription price

Avg: $428

CORALIA CALOMENI MD

Medical Oncology

773

$147K

114
92 are 65+

17%
patients receiving schedule two controlled substances

Avg: 14%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 17%

$190
Average prescription price

Avg: $428

SPENCER SHAO M.D.

Medical Oncology

762

$460K

127
101 are 65+

22%
patients receiving schedule two controlled substances

Avg: 14%

14%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 17%

$604
Average prescription price

Avg: $428

ANUPAMA ACHESON MD

Medical Oncology

698

$71.9K

103
88 are 65+

23%
patients receiving schedule two controlled substances

Avg: 14%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 17%

$103
Average prescription price

Avg: $428

WILLAIM SCHMIDT MD

Medical Oncology

673

$312K

125
102 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

10%
patients receiving schedule three controlled substances

Avg: 6%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 17%

$463
Average prescription price

Avg: $428

NAGENDRA TIRUMALI M.D.

Medical Oncology

653

$538K

162
147 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 17%

$824
Average prescription price

Avg: $428

STACY LEWIS MD

Medical Oncology

642

$315K

117
103 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

13%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 17%

$490
Average prescription price

Avg: $428

ROBERT LUFKIN D.O.

Medical Oncology

641

$376K

117
84 are 65+

21%
patients receiving schedule two controlled substances

Avg: 14%

10%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 17%

$587
Average prescription price

Avg: $428

KEITH LANIER M.D.

Medical Oncology

637

$482K

71
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 17%

$756
Average prescription price

Avg: $428

JANET RUZICH DO

Medical Oncology

609

$237K

113
98 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 17%

$389
Average prescription price

Avg: $428

MICHAEL ONEIL MD

Medical Oncology

586

$201K

114
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 17%

$343
Average prescription price

Avg: $428

BRIAN ERICKSON MD

Medical Oncology

581

$319K

91
77 are 65+

24%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 17%

$549
Average prescription price

Avg: $428

UNKNOWN CHERRY MD

Medical Oncology

557

$386K

138
112 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 17%

$693
Average prescription price

Avg: $428

RACHEL SANBORN MD

Medical Oncology

453

$321K

77
61 are 65+

26%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 17%

$709
Average prescription price

Avg: $428

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank